

Publisher: Bentham Science Publishers
E-ISSN: 1875-5852|3|3|241-246
ISSN: 1568-0053
Source: Current Drug Targets - Infectious Disorders, Vol.3, Iss.3, 2003-09, pp. : 241-246
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Promising Targets for Anti-Hepatitis C Virus Agents
Current Medicinal Chemistry, Vol. 18, Iss. 8, 2011-03 ,pp. :


Nucleosides with anti-hepatitis B virus activity
Expert Opinion on Therapeutic Patents, Vol. 11, Iss. 3, 2001-03 ,pp. :


Design and Development of Anti-Hepatitis B Virus Agents
Current Medicinal Chemistry, Vol. 17, Iss. 29, 2010-10 ,pp. :


New Treatment Targets and Approaches for Hepatitis B Virus
Anti-Infective Agents, Vol. 15, Iss. 1, 2017-04 ,pp. :